Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

Abstract Background Biologics have revolutionized the management of psoriasis, but response to treatment varies. Loss of treatment efficacy may occur over time, requiring treatment switching or escalation. Claims data on persistence may be informative of real-world treatment outcome. This analysis d...

Full description

Saved in:
Bibliographic Details
Main Authors: Timothy Fitzgerald (Author), Maryia Zhdanava (Author), Dominic Pilon (Author), Aditi Shah (Author), Annalise Hilts (Author), Patrick Lefebvre (Author), Steven R. Feldman (Author)
Format: Book
Published: Adis, Springer Healthcare, 2023-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items